Studies have shown that tumor burden, as quantified through these volumetric approaches, exhibits a statistically significant correlation with not only serum PSA levels but also with clinical outcomes such as treatment response, treatment failure, and BCR [41,42]. Here, BCR is linked to neoplasm.